FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088142318> ?p ?o ?g. }

• W2088142318 endingPage "94" @default.
• W2088142318 startingPage "86" @default.
• W2088142318 abstract "A microemulsion system of docetaxel was prepared and evaluated for its solubilization capacity and oral bioavailability improvement. Based on a solubility study and pseudo ternary phase diagrams, microemulsions of about 30 nm in mean diameter were formulated with improved solubilization capacity towards the hydrophobic drug, docetaxel. The o/w microemulsion formulation (M-3) composed of Capryol 90 (oil), Cremophor EL (surfactant) and Transcutol (co-surfactant) enhanced the solubility of docetaxel up to 30 mg/mL, which maintained solubilization capacity for 24 h even after it was diluted 20 times with normal saline. The three formulations did not show significant difference in the in vitro lipid digestion study. Both the ultrafiltration and dialysis studies revealed that the release of 80% of docetaxel was released from the microemulsions within 12 h in vitro. Compared to the commercial product Taxotere® (0.025 µg/cm2), the apical to basolateral transport of docetaxel across the Caco-2 cell monolayer from the M-3 formulation (Capryol 90/Cremophor EL/Transcutol = 29.4:24.9:12.4, w/w) was significantly improved (0.624 µg/cm2, p < 0.01). Moreover, the oral bioavailability of the M-3 formulation in rats (34.42%) rose dramatically compared to that of the orally administered Taxotere® (6.63%). This increase in bioavailability was probably due to the combined effect of the enhancement in solubility, the inhibition of P-gp efflux system and the increase in permeability. These results encourage further development of docetaxel microemulsions as an oral drug delivery system." @default.
• W2088142318 created "2016-06-24" @default.
• W2088142318 creator A5008139770 @default.
• W2088142318 creator A5012894904 @default.
• W2088142318 creator A5028334345 @default.
• W2088142318 creator A5037206227 @default.
• W2088142318 creator A5078895940 @default.
• W2088142318 creator A5080970990 @default.
• W2088142318 creator A5090843485 @default.
• W2088142318 creator A5091547688 @default.
• W2088142318 date "2009-12-01" @default.
• W2088142318 modified "2023-10-16" @default.
• W2088142318 title "Docetaxel microemulsion for enhanced oral bioavailability: Preparation and in vitro and in vivo evaluation" @default.
• W2088142318 cites W1204935804 @default.
• W2088142318 cites W1241822319 @default.
• W2088142318 cites W1490816031 @default.
• W2088142318 cites W1966960575 @default.
• W2088142318 cites W1978965935 @default.
• W2088142318 cites W1983254105 @default.
• W2088142318 cites W1987104113 @default.
• W2088142318 cites W1993648493 @default.
• W2088142318 cites W1996775551 @default.
• W2088142318 cites W2003026126 @default.
• W2088142318 cites W2012479775 @default.
• W2088142318 cites W2014297898 @default.
• W2088142318 cites W2015394617 @default.
• W2088142318 cites W2027950010 @default.
• W2088142318 cites W2046678726 @default.
• W2088142318 cites W2052055688 @default.
• W2088142318 cites W2059052125 @default.
• W2088142318 cites W2070840005 @default.
• W2088142318 cites W2072920570 @default.
• W2088142318 cites W2076863626 @default.
• W2088142318 cites W2087345834 @default.
• W2088142318 cites W2091322268 @default.
• W2088142318 cites W2091483354 @default.
• W2088142318 cites W2107196556 @default.
• W2088142318 cites W2145269041 @default.
• W2088142318 cites W2150549589 @default.
• W2088142318 cites W2151226515 @default.
• W2088142318 cites W2155315199 @default.
• W2088142318 cites W91604478 @default.
• W2088142318 doi "https://doi.org/10.1016/j.jconrel.2009.08.015" @default.
• W2088142318 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19709639" @default.
• W2088142318 hasPublicationYear "2009" @default.
• W2088142318 type Work @default.
• W2088142318 sameAs 2088142318 @default.
• W2088142318 citedByCount "267" @default.
• W2088142318 countsByYear W20881423182012 @default.
• W2088142318 countsByYear W20881423182013 @default.
• W2088142318 countsByYear W20881423182014 @default.
• W2088142318 countsByYear W20881423182015 @default.
• W2088142318 countsByYear W20881423182016 @default.
• W2088142318 countsByYear W20881423182017 @default.
• W2088142318 countsByYear W20881423182018 @default.
• W2088142318 countsByYear W20881423182019 @default.
• W2088142318 countsByYear W20881423182020 @default.
• W2088142318 countsByYear W20881423182021 @default.
• W2088142318 countsByYear W20881423182022 @default.
• W2088142318 countsByYear W20881423182023 @default.
• W2088142318 crossrefType "journal-article" @default.
• W2088142318 hasAuthorship W2088142318A5008139770 @default.
• W2088142318 hasAuthorship W2088142318A5012894904 @default.
• W2088142318 hasAuthorship W2088142318A5028334345 @default.
• W2088142318 hasAuthorship W2088142318A5037206227 @default.
• W2088142318 hasAuthorship W2088142318A5078895940 @default.
• W2088142318 hasAuthorship W2088142318A5080970990 @default.
• W2088142318 hasAuthorship W2088142318A5090843485 @default.
• W2088142318 hasAuthorship W2088142318A5091547688 @default.
• W2088142318 hasConcept C126322002 @default.
• W2088142318 hasConcept C155574463 @default.
• W2088142318 hasConcept C178790620 @default.
• W2088142318 hasConcept C181389837 @default.
• W2088142318 hasConcept C185592680 @default.
• W2088142318 hasConcept C190119865 @default.
• W2088142318 hasConcept C2776694085 @default.
• W2088142318 hasConcept C2781190966 @default.
• W2088142318 hasConcept C43617362 @default.
• W2088142318 hasConcept C55493867 @default.
• W2088142318 hasConcept C58226133 @default.
• W2088142318 hasConcept C71924100 @default.
• W2088142318 hasConcept C98274493 @default.
• W2088142318 hasConceptScore W2088142318C126322002 @default.
• W2088142318 hasConceptScore W2088142318C155574463 @default.
• W2088142318 hasConceptScore W2088142318C178790620 @default.
• W2088142318 hasConceptScore W2088142318C181389837 @default.
• W2088142318 hasConceptScore W2088142318C185592680 @default.
• W2088142318 hasConceptScore W2088142318C190119865 @default.
• W2088142318 hasConceptScore W2088142318C2776694085 @default.
• W2088142318 hasConceptScore W2088142318C2781190966 @default.
• W2088142318 hasConceptScore W2088142318C43617362 @default.
• W2088142318 hasConceptScore W2088142318C55493867 @default.
• W2088142318 hasConceptScore W2088142318C58226133 @default.
• W2088142318 hasConceptScore W2088142318C71924100 @default.
• W2088142318 hasConceptScore W2088142318C98274493 @default.
• W2088142318 hasIssue "2" @default.
• W2088142318 hasLocation W20881423181 @default.
• W2088142318 hasLocation W20881423182 @default.

• next